Navigation Links
Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
Date:7/14/2009

to humans in high concentrations.

"Bacterial contamination in platelets is a serious concern in transfusion medicine," said Darrell J. Triulzi, M.D., medical director of the Institute for Transfusion Medicine and the University of Pittsburgh Medical Center's Division of Transfusion Medicine, which is using the Verax PGD(R) test. "The blood center community has made progress with the implementation of culture-based tests, but these occur at the point of collection when bacteria levels can be too low for detection. A rapid, point-of-care assay, such as the Verax PGD(R) test, takes place just prior to transfusion, which is the best time to detect bacteria levels in platelets and provides a more comprehensive strategy for patient safety."

"Transfusion safety is central to the mission of Fenwal and our customers," said Ron K. Labrum, Fenwal president and chief executive officer. "This agreement is another example of how Fenwal is bringing advanced technology, ideas and performance to our vital industry."

"Fenwal is a pioneer in the development of products that improve blood safety worldwide," said Jim Lousararian, Verax president and chief executive officer. "We are confident that with Fenwal's support we can increase adoption of the Verax PGD(R) test and improve health-care outcomes by reducing transfusion-related issues associated with bacterial contamination."

About Verax Biomedical

Verax Biomedical Inc. is a leading developer of rapid tests for detecting bacterial contaminants in blood cells and tissue. The privately held company was founded in 1999. Its headquarters and laboratory facilities are in Worcester, Massachusetts. The Verax PGD(R) test is currently cleared by the FDA as a rapid, qualitative immunoassay for the detection of bacteria in leukocyte-reduced apheresis platelets as an adjunct quality-control test following previous bacterial testing. For m
'/>"/>

SOURCE Fenwal Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
2. Breakthrough Opportunity for Improving Patient Health
3. DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance
4. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
5. Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction
6. National ePrescribing Patient Safety Initiative Supports Senates Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety
7. Consistency, Flexibility Key in Improving Rewards & Recognition Programs
8. Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes
9. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
10. AARC Presentation Cites Masimo Patient SafetyNet as Key Factor in Improving Patient Outcomes and Reducing Costs in Post-Acute Care Facilities
11. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , Kalifornien und HILDEN, Deutschland, May 26, ... Clinical Insight ®   ... und die Erstellung dazugehöriger Berichte; Vorstellung auf ... QIAGEN N.V. (NASDAQ: QGEN ... die Markteinführung von QIAGEN Clinical Insight ® ...
(Date:5/26/2015)... Inc. (NYSE: ALR ) (the "Company") announced today that, ... Quarterly Report on Form 10-Q for the three months ended ... notice from the New York Stock Exchange (the "NYSE") that ... listing requirements under the timely filing criteria established in Section ... The reason for the delay relates to Company,s need to ...
(Date:5/26/2015)... May 26, 2015   PDI , a ... announced that Oakwood Healthcare in Dearborn, ... winning entry in Delivering the Difference ... display excellence in building collaborative relationships between infection ... healthcare facilities.  Oakwood Healthcare,s infection ...
(Date:5/26/2015)... LOS ANGELES , 26. mája 2015 /PRNewswire/ ... ďakuje v mene svojej rodiny prezidentom Barackovi Obamovi ... vyjadrenú v súvislosti so stratou Dr. Rongxiang ... - http://photos.prnewswire.com/prnh/20150522/218111 Dr. Xu ... svojej dobe a jeho odhodlanie v oblasti vedy ...
Breaking Biology Technology:QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3Dr. Rongxiang Xu, O legende 2
... (NYSE: WPI ), a leading specialty pharmaceutical,company, ... chief,executive officer, will provide an overview and update ... Global Pharmaceutical, Biotechnology and,Medical Device Conference on Tuesday, ... This presentation will be webcast live and ...
... 1 Inverness Medical,Innovations, Inc. (Amex: IMA ... release dated January 31, 2008 and entitled "Inverness ... Pharmaceutical,Biotechnology and Medical Device Conference on February 5, ... the Company,s presentation. The,correct time of the presentation ...
... the Highest Level of Clinical Immunology Expertise, ... Genetic,Immunity(R), a US/Hungarian clinical-stage biopharmaceutical company,focused on the ... announced that it has appointed,Richard B. Pollard, M.D. ... been a leader in HIV/AIDS research for more ...
Cached Biology Technology:Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 3
(Date:5/26/2015)... Research and Markets ( ... "Saudi Arabia Biometric Systems Market Forecast and ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems market in ... to grow at over 22% CAGR through 2020 ... the surging demand for better biometric technologies in ...
(Date:5/25/2015)... SYDNEY , May 25, 2015  Australia,s market ... inception stage, although 2014 saw the advent of several ... on 24 April 2015 is expected to ignite interest ... devices in Australia . This in ... the industry and drive new partnerships amongst vendors and ...
(Date:5/22/2015)... 22, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... be ending its promotional pricing and making the Wocket generally ... Laurence Savin , Head of Marketing said, "We,ve extended the ... the end of May. To get your wocket at this ... open the store on June 1, you,ll receive a unique ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... handmade microscope in 1702, it was Anton van Leeuwenhoek who ... the rapid contraction of a stalk tethering the cell body ... a leaf. Little did van Leeuwenhoek imagine that more than ... set records for speed and power in the nano world ...
... his handmade microscope in 1702, it was Anton van Leeuwenhoek ... observed the rapid contraction of a stalk tethering the cell ... of a leaf. Little did van Leeuwenhoek imagine that more ... would set records for speed and power in the nano ...
... School of Medicine study in the December issue of Lancet ... with white blood cells as a major reason that cancer ... "Cancer cells exhibit a remarkable number of traits normally attributed ... to migrate to lymph nodes and distant organs and to ...
Cached Biology News:Similar Stem Cells In Insect And Human Gut 2Nano springs eternal; Protozoan 'engine' posts nano records 2New evidence supports century-old theory of cancer spread 2
... a DNA-dependent RNA polymerase which is stringently ... efficiently synthesizes in vitro transcripts from almost ... a T7 promoter. Transcripts can be ... vitro translation, substrates in RNA processing systems, ...
... fragment is a proteolytic product ... DNA Polymerase I which retains ... exonuclease activity, but has lost ... retains the polymerization fidelity of ...
... Source: E. coli strain containing an overproducing clone ... catalyzes the formation of a phosphodiester bond between ... duplex DNA or RNA. It repairs single-stranded nicks ... will join both blunt-end and cohesive-end fragments of ...
SHEEP ANTI BOVINE BETA-LACTOGLOBULIN A...
Biology Products: